|Is there a rainbow over the PD road?|
The investigation into the efficacy, safety and tolerability of Cogane has now reached the phase II stage of clinical testing. This trial will be a double-blind, placebo-controlled study. We are not sure if it will be followed by an open label trial - wouldn't that be terrific if this GDNF approach is actually effective.
NCT01060878 is sponsored by Phytopharm. The investigation of Cogane (PYM50028) in Early-stage PD is now recruiting at the following locations:
In the United States
La Jolla, Sacremento and Sunnyvale, California
Quebec City, Quebec
In the United Kingdom
Newcastle upon Tyne, Tyne and Wear